Ethema Health Corporation (GRST)
OTCMKTS
· Delayed Price · Currency is USD
0.0004
+0.0001 (14.29%)
Jun 12, 2025, 11:47 AM EDT
Ethema Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 6.02 | 5.34 | 4.82 | 1.94 | 0.34 | Upgrade
|
| Revenue Growth (YoY) | 12.58% | 10.87% | 148.16% | 473.04% | -5.82% | Upgrade
|
| Cost of Revenue | 3.07 | 2.66 | 1.96 | 0.71 | 0.09 | Upgrade
|
| Gross Profit | 2.94 | 2.69 | 2.86 | 1.23 | 0.25 | Upgrade
|
| Selling, General & Admin | 3.81 | 2.73 | 1.83 | 0.9 | 0.29 | Upgrade
|
| Operating Expenses | 4.28 | 3.23 | 2.37 | 1.23 | 0.41 | Upgrade
|
| Operating Income | -1.33 | -0.54 | 0.49 | 0 | -0.16 | Upgrade
|
| Interest Expense | -0.98 | -0.78 | -1.21 | -2.8 | -1.54 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | - | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.04 | -0.1 | 1.07 | -0.03 | -0.18 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.11 | -0.14 | 0.02 | 0.95 | -7.68 | Upgrade
|
| EBT Excluding Unusual Items | -2.17 | -1.56 | 0.36 | -1.88 | -9.55 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 2.48 | - | - | 0.04 | Upgrade
|
| Other Unusual Items | - | -0.31 | 0.04 | 0.03 | 12.6 | Upgrade
|
| Pretax Income | -2.17 | 0.61 | 0.41 | -1.85 | 3.08 | Upgrade
|
| Income Tax Expense | - | -0.39 | 0.11 | -0.28 | - | Upgrade
|
| Earnings From Continuing Operations | -2.17 | 1.01 | 0.3 | -1.57 | 3.08 | Upgrade
|
| Net Income to Company | -2.17 | 1.01 | 0.3 | -1.57 | 3.08 | Upgrade
|
| Minority Interest in Earnings | 0.1 | 0.17 | -0.05 | 0.03 | - | Upgrade
|
| Net Income | -2.06 | 1.18 | 0.25 | -1.54 | 3.08 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | 0.05 | 0.1 | 0.1 | 0.05 | Upgrade
|
| Net Income to Common | -2.06 | 1.13 | 0.15 | -1.64 | 3.03 | Upgrade
|
| Net Income Growth | - | 374.66% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 5,609 | 3,729 | 3,705 | 2,702 | 1,594 | Upgrade
|
| Shares Outstanding (Diluted) | 5,609 | 3,729 | 3,705 | 2,702 | 2,045 | Upgrade
|
| Shares Change (YoY) | 50.41% | 0.65% | 37.13% | 32.08% | 1402.12% | Upgrade
|
| EPS (Basic) | -0.00 | 0.00 | 0.00 | -0.00 | 0.00 | Upgrade
|
| EPS (Diluted) | -0.00 | 0.00 | 0.00 | -0.00 | 0.00 | Upgrade
|
| EPS Growth | - | 655.00% | - | - | - | Upgrade
|
| Free Cash Flow | -0.76 | -5.78 | 1.26 | -0.22 | -0.1 | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | - | - | - | Upgrade
|
| Gross Margin | 48.94% | 50.30% | 59.29% | 63.31% | 73.88% | Upgrade
|
| Operating Margin | -22.16% | -10.14% | 10.15% | 0.11% | -48.19% | Upgrade
|
| Profit Margin | -34.30% | 21.13% | 3.11% | -84.60% | 894.44% | Upgrade
|
| Free Cash Flow Margin | -12.56% | -108.14% | 26.16% | -11.24% | -30.08% | Upgrade
|
| EBITDA | -0.87 | -0.04 | 1.03 | 0.33 | -0.04 | Upgrade
|
| EBITDA Margin | -14.39% | -0.80% | 21.35% | 16.86% | -12.41% | Upgrade
|
| D&A For EBITDA | 0.47 | 0.5 | 0.54 | 0.33 | 0.12 | Upgrade
|
| EBIT | -1.33 | -0.54 | 0.49 | 0 | -0.16 | Upgrade
|
| EBIT Margin | -22.16% | -10.14% | 10.15% | 0.11% | -48.19% | Upgrade
|
| Effective Tax Rate | - | - | 27.54% | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.